about
Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer.Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancerAn HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.Immune gene expression and response to chemotherapy in advanced breast cancer.mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells.Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosisSpatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencingEffect of CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome indicates endogenous and exogenous interplayDynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancerA Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast CancerPrognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data
P50
Q33718203-CDDEAB70-0EEF-43EF-AC02-FA04036C0973Q34723641-8A346562-8043-4F41-886C-CE11E7521D26Q38863811-B73EC74F-E52B-4213-B259-B3AAADA8A706Q41049696-75E537E2-0E95-44D5-BAF4-0DE76852651EQ46017879-E42D287F-5802-495D-BBF1-3541B740EC38Q47140684-6B623B28-DCBC-437F-BADF-F58B6B2127F3Q49689455-D5F2EE18-232F-410F-9E6B-E8947DB8D5BCQ53409477-4BFF866B-463B-4744-B5CB-64863A96097AQ55400673-67A43763-B95A-490B-984B-9699E89A296FQ57180545-C67618E8-15C9-4B8A-9EDD-1F352ACA0A4CQ59794209-C83C3841-8CC5-496B-89C6-93F4F6D24104Q90326745-223547A2-14C9-4939-A45B-A1F2683207C4Q91523720-0544740C-0EB7-4DE0-86AD-6E1C997241A8Q92234973-D5A32ACF-A3FF-47C2-962C-42ABE2EB6671Q92946101-82E34E65-EC89-4821-8463-125A3D2A401D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John Lövrot
@ast
John Lövrot
@en
John Lövrot
@es
John Lövrot
@nl
John Lövrot
@sl
type
label
John Lövrot
@ast
John Lövrot
@en
John Lövrot
@es
John Lövrot
@nl
John Lövrot
@sl
prefLabel
John Lövrot
@ast
John Lövrot
@en
John Lövrot
@es
John Lövrot
@nl
John Lövrot
@sl
P106
P1153
7401846602
P31
P496
0000-0002-9339-8059